Inventor · disambiguated record
Doris Rau
Also filed as: RAU DORIS
27 granted patents·24 pending applications·540 citations·filing 2006–2025
96Inventor score
Top patents by PatentIndex Score
51 records- 0198US9340621B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted May 17, 2016·91 cites·15 claims
- 0297US9150664B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted Oct 6, 2015·64 cites·15 claims
- 0395US11472886B2Cross-species-specific PSMAxCD3 bispecific single chain antibodyAMGEN RES MUNICH GMBH·Filed 2021·Granted Oct 18, 2022·3 cites·13 claims
- 0495US8236308B2Composition comprising cross-species-specific antibodies and uses thereofKISCHEL ROMAN·Filed 2006·Granted Aug 7, 2012·238 cites·9 claims
- 0594US9598500B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted Mar 21, 2017·22 cites·15 claims
- 0693US10519241B2Antibody constructs for EGFRVIII and CD3AMGEN RES MUNICH GMBH·Filed 2016·Granted Dec 31, 2019·16 cites·22 claims
- 0792US10766969B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted Sep 8, 2020·8 cites·29 claims
- 0892US9982063B2Pharmaceutical compositions with resistance to soluble CEAAMGEN RES MUNICH GMBH·Filed 2016·Granted May 29, 2018·14 cites·25 claims
- 0990US12281176B2Binding molecules for BCMA and CD3AMGEN INC·Filed 2021·Granted Apr 22, 2025·1 cites·7 claims
- 1090US10752694B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2014·Granted Aug 25, 2020·11 cites·15 claims
- 1190US9587036B2Cross-species-specific PSMAxCD3 bispecific single chain antibodyKUFER PETER·Filed 2011·Granted Mar 7, 2017·24 cites·34 claims
- 1288US11987633B2Cross-species-specific single domain bispecific single chain antibodyAMGEN RES MUNICH GMBH·Filed 2021·Granted May 21, 2024·1 cites·27 claims
- 1387US10059766B2Antibody constructs for CDH19 and CD3AMGEN RES MUNICH GMBH·Filed 2014·Granted Aug 28, 2018·9 cites·17 claims
- 1487US8394926B2Pharmaceutical compositions with resistance to soluble CEALUTTERBUESE RALF·Filed 2006·Granted Mar 12, 2013·21 cites·34 claims
- 1586US11155629B2Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3AMGEN RES MUNICH GMBH·Filed 2019·Granted Oct 26, 2021·2 cites·20 claims
- 1685US10981998B2Cross-species-specific single domain bispecific single chain antibodyKUFER PETER·Filed 2009·Granted Apr 20, 2021·5 cites·18 claims
- 1783US2025064927A1Compositions comprising cross-species-specific antibodies and uses thereofAMGEN RES MUNICH GMBH·Filed 2024·Application pending·0 cites
- 1881US2022251243A1Binding molecules for bcma and cd3AMGEN INC·Filed 2022·Application pending·0 cites
- 1980US9695250B2Pharmaceutical compositions with resistance to soluble CEAAMGEN RES MUNICH GMBH·Filed 2013·Granted Jul 4, 2017·4 cites·19 claims
- 2079US11498964B2Antibody constructs for CDH19 and CD3AMGEN RES MUNICH GMBH·Filed 2018·Granted Nov 15, 2022·1 cites·17 claims
- 2178US12441796B2Antibody constructs for CDH19 and CD3AMGEN INC·Filed 2022·Granted Oct 14, 2025·0 cites·17 claims
- 2278US2025346684A1Binding molecules for bcma and cd3AMGEN INC·Filed 2025·Application pending·0 cites
- 2378US2024400673A1Antibody constructs for msln and cd3AMGEN RES MUNICH GMBH·Filed 2023·Application pending·0 cites
- 2477US8901278B2Pharmaceutical antibody compositions with resistance to soluble CEARAU DORIS·Filed 2011·Granted Dec 2, 2014·3 cites·2 claims
- 2576US12281175B2Binding molecules for BCMA and CD3AMGEN INC·Filed 2020·Granted Apr 22, 2025·0 cites·16 claims
- 2676US2025092133A1Bispecific antibody constructs for cdh3 and cd3AMGEN RES MUNICH GMBH·Filed 2024·Application pending·0 cites
- 2775US12281172B2Cross-species-specific PSMAxCD3 bispecific single chain antibodyAMGEN RES MUNICH GMBH·Filed 2021·Granted Apr 22, 2025·0 cites·18 claims
- 2875US12152078B2Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3AMGEN RES MUNICH GMBH·Filed 2021·Granted Nov 26, 2024·0 cites·24 claims
- 2974US11884720B2Antibody constructs for MSLN and CD3AMGEN RES MUNICH GMBH·Filed 2016·Granted Jan 30, 2024·1 cites·23 claims
- 3074US2025163179A1CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODYAMGEN RES MUNICH GMBH·Filed 2025·Application pending·0 cites
- 3171US11925684B2Compositions comprising cross-species-specific antibodies and uses thereofAMGEN RES MUNICH GMBH·Filed 2018·Granted Mar 12, 2024·0 cites·16 claims
- 3270US11028171B2Bispecific antibody constructs for CDH3 and CD3AMGEN RES MUNICH GMBH·Filed 2016·Granted Jun 8, 2021·1 cites·14 claims
- 3367US2011293619A1CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODYKUFER PETER·Filed 2009·Application pending·0 cites
- 3467US2025282863A1Antibody constructs for msln and cd3AMGEN RES MUNICH GMBH·Filed 2025·Application pending·0 cites
- 3566US11926666B2Bispecific antibody constructs for CDH3 and CD3AMGEN RES MUNICH GMBH·Filed 2021·Granted Mar 12, 2024·0 cites·22 claims
- 3664US2020095319A1Cross-species-specific bispecific bindersAMGEN RES MUNICH GMBH·Filed 2019·Application pending·0 cites
- 3764US2023357444A1Cross-species-specific binding domainAMGEN RES MUNICH GMBH·Filed 2022·Application pending·0 cites
- 3863US2010183615A1Cross-species-specific bispecific bindersMICROMET AG·Filed 2008·Application pending·0 cites
- 3962US2020071405A1Antibody constructs for cdh19 and cd3AMGEN RES MUNICH GMBH·Filed 2019·Application pending·0 cites
- 4061US2020362039A1Cross-species-specific pscaxcd3, cd19xcd3, c-metxcd3, endosialinxcd3, epcamxcd3, igf-1rxcd3 or fapalphaxcd3 bispecific single chain antibodyAMGEN RES MUNICH GMBH·Filed 2019·Application pending·0 cites
- 4161US2019169310A1CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODYAMGEN RES MUNICH GMBH·Filed 2018·Application pending·0 cites
- 4261US2025282869A1Heteromultimer binding dll3 and cd3AMGEN INC·Filed 2023·Application pending·0 cites
- 4359US2012034228A1CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODYKUFER PETER·Filed 2009·Application pending·0 cites
- 4457US2013129729A1Compositions comprising cross-species-specific antibodies and uses thereofKISCHEL ROMAN·Filed 2012·Application pending·0 cites
- 4556US2012244162A1Cross-species-specific bispecific bindersKUFER PETER·Filed 2012·Application pending·0 cites
- 4655US2024209078A1Multitargeting bispecific antigen-binding molecules of increased selectivityAMGEN INC·Filed 2021·Application pending·0 cites
- 4754US2009226444A1Pharmaceutical antibody compositions with resistance to soluble ceaMICROMET AG·Filed 2006·Application pending·0 cites
- 4853US2023406929A1Polypeptide constructs binding to cd3AMGEN INC·Filed 2021·Application pending·0 cites
- 4953US2016152707A1Cross-species-specific bispecific bindersAMGEN RES MUNICH GMBH·Filed 2015·Application pending·0 cites
- 5049US2010150918A1Cross-species-specific binding domainMICROMET AG·Filed 2008·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Doris Rau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →